Your browser doesn't support javascript.
loading
Changes in cancer incidence and survival among Aboriginal and Torres Strait Islander children in Australia, 1997-2016.
Youlden, Danny R; Baade, Peter D; McBride, Craig A; Pole, Jason D; Moore, Andrew S; Valery, Patricia C; Young, Angela; Aitken, Joanne F.
Afiliación
  • Youlden DR; Cancer Council Queensland, Brisbane, Queensland, Australia.
  • Baade PD; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • McBride CA; Cancer Council Queensland, Brisbane, Queensland, Australia.
  • Pole JD; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • Moore AS; School of Mathematical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Valery PC; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • Young A; Department of Paediatric Surgery, Queensland Children's Hospital, Brisbane, Queensland, Australia.
  • Aitken JF; Discipline of Paediatrics and Child Health, The University of Queensland, Brisbane, Queensland, Australia.
Pediatr Blood Cancer ; 69(4): e29492, 2022 04.
Article en En | MEDLINE | ID: mdl-34908222
ABSTRACT

BACKGROUND:

This study reports cancer incidence and survival among Aboriginal and Torres Strait Islander children and other Australian children, and assesses changes over time. PROCEDURE Data were from the population-based Australian Childhood Cancer Registry. The study comprised children aged under 15 diagnosed between 1997 and 2016 and with mortality follow-up until 31 December 2017. Incidence trends were analysed using JoinPoint regression. Five-year cancer-specific survival was calculated using the semi-complete approach with survival comparisons made using multivariable flexible parametric models.

RESULTS:

Aboriginal and Torres Strait Islander children accounted for 506 of 13,299 eligible cases (3.8%). Incidence rates for Aboriginal and Torres Strait Islander children across the study period increased by 2.3% annually (95% confidence interval [CI] +0.6% to +4.0%) and for other Australian children increased by 0.6% annually (95% CI +0.3% to +0.9%; p = .05). Nonetheless, cancer incidence was consistently lower for Aboriginal and Torres Strait Islander children, with an incidence rate ratio of 0.73 (95% CI 0.62-0.85; p < .01) between 2012 and 2016. Survival for Aboriginal and Torres Strait Islander children with solid tumours was 70.6% (95% CI 62.5%-77.3%) and for other Australian children was 83.5% (95% CI 82.3%-84.7%; p < .01), with indications of this difference diminishing in recent years.

CONCLUSIONS:

Improvements in identification, particularly in urban areas, most likely accounts for the greater increase in cancer incidence rates among Aboriginal and Torres Strait Islander children. Examination of data on stage at diagnosis and treatment may provide important insights into survival for children with solid tumours.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nativos de Hawái y Otras Islas del Pacífico / Neoplasias Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans País/Región como asunto: Oceania Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nativos de Hawái y Otras Islas del Pacífico / Neoplasias Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans País/Región como asunto: Oceania Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Australia